A polysaccharide from mushroom Huaier retards human hepatocellular carcinoma growth, angiogenesis, and metastasis in nude mice

Tumor Biology

Volumn 36, Issue 4, 2015, Pages 2929-2936

  Zou, Yanmei ^a,b,c   Xiong, Hua ^a,b,c   Xiong, Huihua ^a,b,c   Lu, Tao ^a,b,c   Zhu, Feng ^a,b,c   Luo, Zhiyong ^a,b,c   Yuan, Xianglin ^a,b,c   Wang, Yihua ^a,b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Angiogenesis; Huaier purified polysaccharide; Metastasis

Indexed keywords

POLYSACCHARIDE; TUMOR PROTEIN;

AGARICALES; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER NEOPLASMS; METASTASIS; MOUSE; PATHOLOGY; TUMOR CELL LINE;

AGARICALES; ANIMALS; APOPTOSIS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; POLYSACCHARIDES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84936746958     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2923-8     Document Type: Article

References (44)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.
3. Wang J, Zheng X, Zeng G, Zhou Y, Yuan H. Purified vitexin compound 1 inhibits growth and angiogenesis through activation of FOXO3a by inactivation of Akt in hepatocellular carcinoma. Int J Mol Med. 2014;33:441–8.
4. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271–85.
5. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.
6. Drake CG, Antonarakis ES. Update: immunological strategies for prostate cancer. Curr Urol Rep. 2010;11:202–7.
7. Kellof GJ. Perspective on cancer chemoprevention research and drug development. Adv Cancer Res. 2000;78:199–334.
8. Cohen I, Tagliaferri M, Tripathy D. Traditional Chinese medicine in the treatment of breast cancer. Semin Oncol. 2002;29:563–74.
9. Li L, Ye S, Wang Y. Progress on experimental research and clinical application of Trametes robiniophila. Bull Chin Cancer. 2007;2:016.
10. Zhang T, Wang K, Zhang J, Wang X, Chen Z, Ni C, et al. Huaier aqueous extract inhibits colorectal cancer stem cell growth partially via downregulation of the Wnt/β-catenin pathway. Oncol Lett. 2013;5:1171–6.
11. Ren J, Zheng C, Feng G, Liang H, Xia X, Fang J, et al. Inhibitory effect of extract of fungi of Huaier on hepatocellular carcinoma cells. J Huazhong Univ Sci Techn Med Sci. 2009;29:198–201.
12. Zhang N, Kong X, Yan S, Yuan C, Yang Q. Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis. Cancer Sci. 2010;101:2375–83.
13. Xu X, Wei Q, Wang K, Ling Q, Xie H, Zhou L, et al. Anticancer effects of Huaier are associated with down-regulation of P53. Asian Pac J Cancer Prev. 2011;12:2251–4.
14. Guo Y, Cheng P, Chen Y, Zhou X, Yu P, Li Y. Studies on the constituents of polysaccharide from the hyphae of Trametes robiniophila (II)—identification of polysaccharide from the hyphae of Trametes robiniophila and determination of its molar ratio. J China Pharm Univ. 1992;23:155–7.
15. Guo Y, Cheng P, Chen Y, Zhou X, Yu P, Li Y. Isolation and analysis of the polysaccharide of Huaier mycelium. Chin J Biochem Pharm. 1993;63:56–9.
16. Zheng J, Li C, Wu X, Liu M, Sun X, Yang Y, et al. Huaier polysaccharides suppresses hepatocarcinoma MHCC97-H cell metastasis via inactivation of EMT and AEG-1 pathway. Int J Biol Macromol. 2014;64:106–10.
17. Li C, Wu X, Zhang H, Yang G, Hao M, Sheng S, et al. A Huaier polysaccharide inhibits hepatocellular carcinoma growth and metastasis. Tumour Biol. 2014. doi:10.1007/s13277-014-2775-2.
18. Staub AM. Removal of protein-Sevag method. Methods Carbohydr Chem. 1965;5:5–6.
19. Liu X, Zu YG, Fu YJ, Yao LP, Gu CB, Wang W, et al. Antimicrobial activity and cytotoxicity towards cancer cells of Melaleuca alternifolia (tea tree) oil. Eur Food Res Technol. 2009;229:247–53.
20. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8.
21. Haifeng J, Yanglin P, Lijie H, Huihong Z, Xiaohua L, Lina Z, et al. p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer. Mol Cancer Res. 2007;5:423–33.
22. Han MH, Lee WS, Lu JN, Kim G, Jung JM, Ryu CH, et al. Citrus aurantium L. exhibits apoptotic effects on U937 human leukemia cells partly through inhibition of Akt. Int J Oncol. 2012;40:2090–6.
23. Liu S, Yu M, He Y, Xiao L, Wang F, Song C, et al. Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology. 2008;47:1964–73.
24. Sun HC, Tang ZY, Li XM, Zhou YN, Sun BR, Ma ZC. Immunohistochemical study of angiogenesis in hepatocellular carcinoma: its relationship with prognosis. J Cancer Res Clin Oncol. 1999;125:419–26.
25. Martínez A. A new family of angiogenic factors. Cancer Lett. 2006;236:157–63.
26. Jakob C, Sterz J, Zavrski I, Heider U, Kleeberg L, Fleissner C, et al. Angiogenesis in multiple myeloma. Eur J Cancer. 2006;42:1581–90.
27. Pang RW, Joh JW, Johnson PJ, Monden M, Pawlik TM, Poon RT. Biology of hepatocellular carcinoma. Ann Surg Oncol. 2008;15:962–71.
28. Barr MP, Bouchier-Hayes DJ, Harmey JJ. Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia. Int J Oncol. 2008;32:41–8.
29. Tzao C, Lee SC, Tung HJ, Hsu HS, Hsu WH, Sun GH, et al. Expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma. Dis Markers. 2008;25:141–8.
30. Lin C, McGough R, Aswad B, Block JA, Terek R. Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes. J Orthop Res. 2004;22:1175–81.
31. Shimamura T, Saito S, Morita K, Kitamura T, Morimoto M, Kiba T, et al. Detection of vascular endothelial growth factor and its receptor expression in human hepatocellular carcinoma biopsy specimens. J Gastroenterol Hepatol. 2000;15:640–6.
32. Ng KT, Guo DY, Cheng Q, Geng W, Ling CC, Li CX, et al. A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma. PLoS ONE. 2012;7:e31655.
33. Wang L, Tang ZY, Qin LX, Wu XF, Sun HC, Xue Q, et al. gh-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential. Hepatol. 2000;32:43–8.
34. Cho JY, Chung HC, Noh SH, Roh JK, Min JS, Kim BS. High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma. Cancer. 1997;79:878–83.
35. Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Ann N Y Acad Sci. 2001;936:406–12.
36. Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev. 2004;23:101–17.
37. Sugita K. Recent advances in inhibitors of metalloproteinases for cancer therapy. IDrugs. 1999;2:327–39.
38. Wojtowicz-Praga S. Clinical potential of matrix metalloproteinase inhibitors. Drugs Res Dev. 1999;1:117–29.
39. Sarrió D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 2008;68:989–97.
40. Fransvea E, Angelotti U, Antonaci S, Giannelli G. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Hepatology. 2008;47:1557–66.
41. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9:798–809.
42. Long M, Hao M, Dong K, Shen J, Wang X, Lin F, et al. AEG-1 overexpression is essential for maintenance of malignant state in human AML cells via up-regulation of Akt1 mediated by AURKA activation. Cell Signal. 2013;25:1438–46.
43. Yang SF, Wang SN, Wu CF, Yeh YT, Chai CY, Chunag SC, et al. Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma. J Clin Pathol. 2007;60:642–8.
44. Srivastava J, Siddiq A, Emdad L, Santhekadur PK, Chen D, Gredler R, et al. Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model. Hepatology. 2012;56:1782–91.